Active Ingredient: DEXLANSOPRAZOLE
Proprietary Name: DEXILANT SOLUTAB
Dosage Form; Route of Administration: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE; ORAL
Strength: 30MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N208056
Product Number: 001
Approval Date: Jan 26, 2016
Applicant Holder Full Name: TAKEDA PHARMACEUTICALS USA INC
Marketing Status:
Discontinued
Patent and Exclusivity Information
